Comparative Pharmacology
Head-to-head clinical analysis: CEFADYL versus CEFAZOLIN AND DEXTROSE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CEFADYL versus CEFAZOLIN AND DEXTROSE.
CEFADYL vs CEFAZOLIN AND DEXTROSE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Bactericidal; inhibits cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidation and autolysin activation.
Bactericidal agent inhibiting bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), disrupting peptidoglycan cross-linking, leading to cell lysis. Dextrose provides osmotic diuresis and energy source.
1-2 g IV/IM every 6 hours for moderate to severe infections; maximum 12 g/day.
1-2 g IV/IM every 8 hours; maximum 12 g/day.
None Documented
None Documented
30-60 minutes in adults with normal renal function; prolonged to 10-20 hours in end-stage renal disease. Requires dose adjustment for CrCl <30 mL/min.
1.8 hours (prolonged to 20-40 hours in severe renal impairment, CrCl <10 mL/min)
Renal: 90-95% unchanged via glomerular filtration and tubular secretion. Biliary: <1%. Fecal: minimal.
Renal (80-90% unchanged via glomerular filtration and tubular secretion); biliary/fecal (<5%)
Category C
Category A/B
Cephalosporin Antibiotic
Cephalosporin Antibiotic